DEVELOPMENT AND CHARACTERIZATION OF MUCOADHESIVE MICROSPHERE-LOADED INTRANASAL GEL OF VENLAFAXINE HYDROCHLORIDE

Authors

  • Bhupen Kalita
  • Kritika Saikia ASTU
  • Banasmita Kalita

DOI:

https://doi.org/10.22159/ajpcr.2016.v9s3.13057

Abstract

ABSTRACT
Objective: The main objective of the present work is to develop and characterize a novel mucoadhesive intranasal microsphere gel formulation of
drug venlafaxine to control the drug release through nasal mucosa and reach the target site with minimal side effect. The objectives of the study
are (1) formulation of mucoadhesive microspheres, (2) evaluation of mucoadhesive microspheres, (3) formulation of mucoadhesive microsphereloaded
nasal gel, (4) and evaluation of nasal gel.
Methods: Preparation of chitosan microsphere: The chitosan microspheres were prepared by emulsion cross-linking method. Preparation of
microsphere-loaded gel: The nasal gels with varying concentrations of Carbopol 934P were prepared by dispersing required quantity of Carbopol in
required quantity of distilled water with continuous stirring and kept overnight for complete hydration. The gel was then modified by the addition of
varying proportion of hydroxypropyl methylcellulose (HPMC) K4M.
Results: The prepared microspheres were evaluated for size distribution, surface morphology by scanning electron microscopy, entrapment efficiency,
compatibility by Fourier transform infrared spectroscopy, and differential scanning calorimetry. Entrapment efficiency of all formulations was found
more than 70%. Microsphere formulation containing drug and polymer in the ratio of 1:2.5 was found to be optimized. Optimized microsphere
formulation was then incorporated in gel prepared using Carbopol 934P and HPMC. Prepared gel formulations were studied for viscosity, spreadability,
and in-vitro drug release in simulated nasal conditions. Viscosity of the optimized batch of gel was recorded at 1056 centipoise. Drug release was
prolonged for the microsphere-in-gel formulations compared to the microspheres alone. For the optimized batch of gel, cumulative drug release of
85.67% was found after 8 hrs.
Conclusion: The results suggest that venlafaxine hydrochloride mucoadhesive microsphere-loaded nasal gel would give sustained drug release and
superior bioavailability in the brain sites.
Keywords: Venlafaxine, Chitosan, Mucoadhesive, Microsphere, Nasal gel.

Downloads

Download data is not yet available.

Author Biography

Kritika Saikia, ASTU

DEPARTMENT OF PHARMACEUTRICAL SCIENCE,M.PHARM SCHOLAR

References

Nasare L, Niranjane K, Nagdevte A, SumedhMohril, Nasal drug delivery system: An emerging approach for brain targeting. World J Pharm Sci 2014;3(4):539-53.

Bhosale AV, Chaudhari PD. A review on nose-to-brain drug delivery. Int J Pharm Sci Rev Res 2013;2(1):516-25.

Dhakar RC. Non-invasive systemic drug delivery via nasal route: A review. AJPSP 2011;2(1):114-44.

Dhakar RC, Maurya SD, Tilak VK, Gupta AK. A review on factors affecting the design of nasal drug delivery system. Int J Drug Deliv 2011;3:194-208.4.

Chaudhari A, Jadhav KR, Kadam VJ. An overview: Microspheres as a nasal drug delivery system. Approach for brain targeting. WJPR. Int J Pharm Sci Rev Res 2014;3(4):539-53.

Illum L. Nasal drug delivery - possibilities, problems and solutions. J Control Release 2003;87(1-3):187-98.

Gowri R, Narayanan N, Maheswaran A, Janarthanan S, Paulra S, Lavanya P. Mucoadhesive microspheres - A virtuous bioavailability embellishing tool. Int J Pharm 2013;3(4):763-73.

Vasir JK, Tambwekar K, Garg S. Bioadhesive microspheres as a controlled drug delivery system. Int J Pharm 2003;255(1-2):13-32.

Desai S, Vidyasagar G, Shah V, Desai D. Preparation and in-vitro characterization of mucoadhesive microspheres of Midazolam: Nose to brain administration. Asian J Pharm Clin Res 2011;4(1):100-2.

Gavini E, Hegge AB, Rassu G, Sanna V, Testa C, Pirisino G, et al. Nasal administration of carbamazepine using chitosan microspheres: In vitro/in vivo studies. Int J Pharm 2006;307(1):9-15.

Doddayya H, Srishailgouda SP, Reddy BT, Kumar P, Rajagopal HU, Shree MV. Formulation and evaluation of brain-targeted nasal selegiline hydrochloride microspheres. Int J Pharm Biomed Res 2014;5(3):61-8.

Rathananand M, Kumar DS, Shirwaikar A, Kumar R, Sampath DK, Prasad RS. Preparation of mucoadhesive microspheres for nasal delivery by spray drying. Indian J Pharm Sci 2007;69(5):651-7.

Jose S, Ansa CR, Cinu TA, Chacko AJ, Aleykutty NA, Ferreira SV, et al. Thermosensitive gels containing Lorazepam microspheres for brain targeting. Int J Pharm 2013;441:516-26.

Gaikwad M, Sahasrabuddhe S, Puranik P. Development and evaluation of carbamazepine loaded transfersomal in-situ gel for nose to brain delivery. Indo Am J Pharm Res 2015;5(05):47-53.

Bhandwalkar MJ, Avachat AM. Thermoreversible nasal in situgel of venlafaxine hydrochloride: Formulation, characterization and pharmacodynamic evaluation. AAPS PharmSciTech 2013;14(1):101-10.

Dandagi PM, Sharma R, Gadad AP, Mastiholimath V. Thermo sensitive gels containing carbamazepine microspheres for intranasal targeting. WJPR 2014;3(9):716-30.

Hardenia SS, Jain A, Patel A, Kaushal A. Formulation and evaluation of mucoadhesive microspheres of ciprofloxacin. JAPER 2011;1(4):214-4.

Senthil A, Kumar RB, Vinod BD, Bharat BL, Battu BL. Formulation and evaluation of mucoadhesive microspheres of venlafexine HCl. Int Res J Pharm 2011;2(4):194-9.

Dada Khalandar KS, Yajaman S, Jayaveera KN. Chitosan based nasal microspheres of sumatriptan: Formulation and in-vitro evaluation. Res J Pharm Biol Chem Sci 2011;2(3):489-98.

Deshpande T, Masareddy R, Bolmal U. Development of mucoadhesive microspheres for nasal delivery of sumatriptan. Int J Pharm Sci Rev Res 2011;7(2):193-7.

Majithiya RJ, Ghosh PK, Umrethia ML, Murthy RS. Thermoreversible-mucoadhesive gel for nasal delivery of sumatriptan. AAPS PharmSciTech 2006;7(3):67.

Published

01-12-2016

How to Cite

Kalita, B., K. Saikia, and B. Kalita. “DEVELOPMENT AND CHARACTERIZATION OF MUCOADHESIVE MICROSPHERE-LOADED INTRANASAL GEL OF VENLAFAXINE HYDROCHLORIDE”. Asian Journal of Pharmaceutical and Clinical Research, vol. 9, no. 9, Dec. 2016, pp. 139-44, doi:10.22159/ajpcr.2016.v9s3.13057.

Issue

Section

Original Article(s)